{"id":234005,"date":"2025-08-14T07:05:45","date_gmt":"2025-08-14T07:05:45","guid":{"rendered":"https:\/\/ipsnews.net\/business\/2025\/08\/14\/dutyfreemeds-com-expands-affordable-access-to-breakthrough-weight-loss-drug-zepbound-for-u-s-patients\/"},"modified":"2025-08-17T18:35:02","modified_gmt":"2025-08-17T18:35:02","slug":"dutyfreemeds-com-expands-affordable-access-to-breakthrough-weight-loss-drug-zepbound-for-u-s-patients","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2025\/08\/14\/dutyfreemeds-com-expands-affordable-access-to-breakthrough-weight-loss-drug-zepbound-for-u-s-patients\/","title":{"rendered":"DutyFreeMeds.com Expands Affordable Access to Breakthrough Weight Loss Drug Zepbound for U.S. Patients"},"content":{"rendered":"
\"\"<\/figure>\n

Manitoba, CA \u2014 18 July 2025 \u2014 Americans struggling with obesity now have a more affordable way to access Zepbound (tirzepatide), a groundbreaking weight loss drug developed by Eli Lilly. DutyFreeMeds.com<\/a>, a Manitoba-based prescription fulfillment service, is among the first to offer the medication to U.S. patients at prices well below typical U.S. retail costs.<\/p>\n

\u201cUnlike USA Zepbound, which comes as a single-dose pen, these are multi-dose pens. One pen = four Doses,\u201d says Duty Free Meds spokesperson Hank Popeil. \u201cThe pens DO NOT come with needles. But needles can be purchased separately.\u201d<\/p>\n

Zepbound has drawn global attention for its unmatched results in clinical trials. In Eli Lilly\u2019s SURMOUNT-1 Phase 3 study, patients lost an average of up to 22.5% of their body weight after 72 weeks of treatment \u2014 a level of effectiveness comparable to bariatric surgery. The drug works by activating two gut hormone receptors \u2014 GLP-1 and GIP \u2014 to suppress appetite, regulate insulin, and promote sustained weight loss.<\/p>\n

\u201cThis is a major leap forward in the treatment of obesity,\u201d said Dr. Robert Kushner, lead author of the SURMOUNT-1 trial and Professor of Medicine at Northwestern University Feinberg School of Medicine.<\/p>\n

While Zepbound\u2019s U.S. retail price can exceed $1,000 per month without insurance, Duty Free Meds sources the medication from licensed international pharmacies, ensuring safety, quality, and transparent pricing without unnecessary markups. The company ships exclusively to U.S. patients.<\/p>\n

\u201cToo many patients are priced out of life-changing treatments,\u201d said Dr. Yoni Freedhoff, Canadian obesity expert and Associate Professor at the University of Ottawa. \u201cImproved accessibility through regulated international providers is a step in the right direction.\u201d<\/p>\n

About Duty Free Meds
Duty Free Meds is a trusted prescription fulfillment service based in Manitoba, Canada, dedicated to helping U.S. patients access affordable, high-quality medications. By partnering with licensed pharmacies and certified healthcare professionals, Duty Free Meds ensures all products meet Health Canada standards. The company has helped thousands of Americans reduce out-of-pocket prescription costs through convenient, secure online ordering.<\/p>\n

For more information, visit www.dutyfreemeds.com<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

Manitoba, CA \u2014 18 July 2025 \u2014 Americans struggling with obesity now have a more affordable way to access Zepbound (tirzepatide), a groundbreaking weight loss drug developed by Eli Lilly. DutyFreeMeds.com, a Manitoba-based prescription fulfillment service, is among the first… Continue Reading →<\/span><\/a><\/p>\n","protected":false},"author":353,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[57],"tags":[],"class_list":["post-234005","post","type-post","status-publish","format-standard","hentry","category-ips"],"yoast_head":"\nDutyFreeMeds.com Expands Affordable Access to Breakthrough Weight Loss Drug Zepbound for U.S. Patients - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipsnews.net\/business\/2025\/08\/14\/dutyfreemeds-com-expands-affordable-access-to-breakthrough-weight-loss-drug-zepbound-for-u-s-patients\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DutyFreeMeds.com Expands Affordable Access to Breakthrough Weight Loss Drug Zepbound for U.S. Patients - Business\" \/>\n<meta property=\"og:description\" content=\"Manitoba, CA \u2014 18 July 2025 \u2014 Americans struggling with obesity now have a more affordable way to access Zepbound (tirzepatide), a groundbreaking weight loss drug developed by Eli Lilly. DutyFreeMeds.com, a Manitoba-based prescription fulfillment service, is among the first… Continue Reading →\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipsnews.net\/business\/2025\/08\/14\/dutyfreemeds-com-expands-affordable-access-to-breakthrough-weight-loss-drug-zepbound-for-u-s-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-14T07:05:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-17T18:35:02+00:00\" \/>\n<meta name=\"author\" content=\"WB News\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"WB News\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ipsnews.net\/business\/2025\/08\/14\/dutyfreemeds-com-expands-affordable-access-to-breakthrough-weight-loss-drug-zepbound-for-u-s-patients\/\",\"url\":\"https:\/\/ipsnews.net\/business\/2025\/08\/14\/dutyfreemeds-com-expands-affordable-access-to-breakthrough-weight-loss-drug-zepbound-for-u-s-patients\/\",\"name\":\"DutyFreeMeds.com Expands Affordable Access to Breakthrough Weight Loss Drug Zepbound for U.S. Patients - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2025\/08\/14\/dutyfreemeds-com-expands-affordable-access-to-breakthrough-weight-loss-drug-zepbound-for-u-s-patients\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2025\/08\/14\/dutyfreemeds-com-expands-affordable-access-to-breakthrough-weight-loss-drug-zepbound-for-u-s-patients\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wikiblogsnews.com\/wp-content\/uploads\/2025\/08\/1000735037-1024x682.jpg\",\"datePublished\":\"2025-08-14T07:05:45+00:00\",\"dateModified\":\"2025-08-17T18:35:02+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/ca2826f2ff17ff03632e1f409743ec86\"},\"breadcrumb\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2025\/08\/14\/dutyfreemeds-com-expands-affordable-access-to-breakthrough-weight-loss-drug-zepbound-for-u-s-patients\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ipsnews.net\/business\/2025\/08\/14\/dutyfreemeds-com-expands-affordable-access-to-breakthrough-weight-loss-drug-zepbound-for-u-s-patients\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/2025\/08\/14\/dutyfreemeds-com-expands-affordable-access-to-breakthrough-weight-loss-drug-zepbound-for-u-s-patients\/#primaryimage\",\"url\":\"https:\/\/wikiblogsnews.com\/wp-content\/uploads\/2025\/08\/1000735037-1024x682.jpg\",\"contentUrl\":\"https:\/\/wikiblogsnews.com\/wp-content\/uploads\/2025\/08\/1000735037-1024x682.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ipsnews.net\/business\/2025\/08\/14\/dutyfreemeds-com-expands-affordable-access-to-breakthrough-weight-loss-drug-zepbound-for-u-s-patients\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"DutyFreeMeds.com Expands Affordable Access to Breakthrough Weight Loss Drug Zepbound for U.S. Patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/ca2826f2ff17ff03632e1f409743ec86\",\"name\":\"WB News\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d321853922d07597545d3dce53ed02a93393c31d358a6fe9c3565e052652022e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d321853922d07597545d3dce53ed02a93393c31d358a6fe9c3565e052652022e?s=96&d=mm&r=g\",\"caption\":\"WB News\"},\"sameAs\":[\"https:\/\/wikiblogsnews.com\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/wb-news\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DutyFreeMeds.com Expands Affordable Access to Breakthrough Weight Loss Drug Zepbound for U.S. Patients - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipsnews.net\/business\/2025\/08\/14\/dutyfreemeds-com-expands-affordable-access-to-breakthrough-weight-loss-drug-zepbound-for-u-s-patients\/","og_locale":"en_US","og_type":"article","og_title":"DutyFreeMeds.com Expands Affordable Access to Breakthrough Weight Loss Drug Zepbound for U.S. Patients - Business","og_description":"Manitoba, CA \u2014 18 July 2025 \u2014 Americans struggling with obesity now have a more affordable way to access Zepbound (tirzepatide), a groundbreaking weight loss drug developed by Eli Lilly. DutyFreeMeds.com, a Manitoba-based prescription fulfillment service, is among the first… Continue Reading →","og_url":"https:\/\/ipsnews.net\/business\/2025\/08\/14\/dutyfreemeds-com-expands-affordable-access-to-breakthrough-weight-loss-drug-zepbound-for-u-s-patients\/","og_site_name":"Business","article_published_time":"2025-08-14T07:05:45+00:00","article_modified_time":"2025-08-17T18:35:02+00:00","author":"WB News","twitter_card":"summary_large_image","twitter_misc":{"Written by":"WB News","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ipsnews.net\/business\/2025\/08\/14\/dutyfreemeds-com-expands-affordable-access-to-breakthrough-weight-loss-drug-zepbound-for-u-s-patients\/","url":"https:\/\/ipsnews.net\/business\/2025\/08\/14\/dutyfreemeds-com-expands-affordable-access-to-breakthrough-weight-loss-drug-zepbound-for-u-s-patients\/","name":"DutyFreeMeds.com Expands Affordable Access to Breakthrough Weight Loss Drug Zepbound for U.S. Patients - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ipsnews.net\/business\/2025\/08\/14\/dutyfreemeds-com-expands-affordable-access-to-breakthrough-weight-loss-drug-zepbound-for-u-s-patients\/#primaryimage"},"image":{"@id":"https:\/\/ipsnews.net\/business\/2025\/08\/14\/dutyfreemeds-com-expands-affordable-access-to-breakthrough-weight-loss-drug-zepbound-for-u-s-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/wikiblogsnews.com\/wp-content\/uploads\/2025\/08\/1000735037-1024x682.jpg","datePublished":"2025-08-14T07:05:45+00:00","dateModified":"2025-08-17T18:35:02+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/ca2826f2ff17ff03632e1f409743ec86"},"breadcrumb":{"@id":"https:\/\/ipsnews.net\/business\/2025\/08\/14\/dutyfreemeds-com-expands-affordable-access-to-breakthrough-weight-loss-drug-zepbound-for-u-s-patients\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipsnews.net\/business\/2025\/08\/14\/dutyfreemeds-com-expands-affordable-access-to-breakthrough-weight-loss-drug-zepbound-for-u-s-patients\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/2025\/08\/14\/dutyfreemeds-com-expands-affordable-access-to-breakthrough-weight-loss-drug-zepbound-for-u-s-patients\/#primaryimage","url":"https:\/\/wikiblogsnews.com\/wp-content\/uploads\/2025\/08\/1000735037-1024x682.jpg","contentUrl":"https:\/\/wikiblogsnews.com\/wp-content\/uploads\/2025\/08\/1000735037-1024x682.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/ipsnews.net\/business\/2025\/08\/14\/dutyfreemeds-com-expands-affordable-access-to-breakthrough-weight-loss-drug-zepbound-for-u-s-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"DutyFreeMeds.com Expands Affordable Access to Breakthrough Weight Loss Drug Zepbound for U.S. Patients"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/ca2826f2ff17ff03632e1f409743ec86","name":"WB News","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d321853922d07597545d3dce53ed02a93393c31d358a6fe9c3565e052652022e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d321853922d07597545d3dce53ed02a93393c31d358a6fe9c3565e052652022e?s=96&d=mm&r=g","caption":"WB News"},"sameAs":["https:\/\/wikiblogsnews.com"],"url":"https:\/\/ipsnews.net\/business\/author\/wb-news\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/234005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/353"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=234005"}],"version-history":[{"count":1,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/234005\/revisions"}],"predecessor-version":[{"id":234130,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/234005\/revisions\/234130"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=234005"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=234005"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=234005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}